These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 5347028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of gout with allopurinol. (Study of 106 cases)].
    Delbarre F, Auscher C, Amor B, de Géry A.
    Sem Hop; 1967 Feb 26; 43(10):634-43. PubMed ID: 4292982
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA, Krömer H, Scott JT, Watts RW.
    Clin Sci; 1968 Oct 26; 35(2):353-62. PubMed ID: 5721238
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F, Saporta L, de Géry A, Jabre E.
    Rev Rhum Mal Osteoartic; 1970 Oct 26; 37(6):443-50. PubMed ID: 5453852
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antihyperuricemic properties of amflutizole in gout.
    Wortmann RL, Ridolfo AS, Lightfoot RW, Fox IH.
    J Rheumatol; 1985 Jun 26; 12(3):540-3. PubMed ID: 3900392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gout management: let's get it right this time.
    Sundy JS.
    Arthritis Rheum; 2008 Nov 15; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract] [Full Text] [Related]

  • 15. Febuxostat for prevention of gout attacks.
    Pohar S, Murphy G.
    Issues Emerg Health Technol; 2006 Aug 15; (87):1-4. PubMed ID: 16958189
    [Abstract] [Full Text] [Related]

  • 16. Hyperuricemia and gout.
    Lo B.
    West J Med; 1985 Jan 15; 142(1):104-7. PubMed ID: 3976216
    [No Abstract] [Full Text] [Related]

  • 17. Approach to the treatment of hyperuricemia.
    Poon SH, Hall HA, Zimmermann B.
    Med Health R I; 2009 Nov 15; 92(11):359-62. PubMed ID: 19999894
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.
    Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.